Tanzania: TB Research
Location: Dar es Salaam, Tanzania
Deadline to Apply: February 17, 2017 5:00 pm
The DarDar Program was established as a research collaboration between Dartmouth’s Geisel school of Medicine and the Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania in 2001. The name DarDar mimics the Kiswahili word for sister, “dada”, and connotes the strong partnership between the two institutions. Since its inception, the DarDar Program has supported clinical service delivery at MUHAS while conducting extensive clinical research and training clinicians and researchers from both institutions. In 2013, researchers from the Geisel School were awarded a grant from the NIH Fogarty International Center to establish the first HIV-TB institute in East Africa.
Website link: http://geiseldardar.org
DarDar researchers will launch a new study in 2017 to examine the feasibility, adherence, tolerability, and safety of isoniazid preventative therapy (IPT) for the prevention of tuberculosis in HIV positive children in an HIV treatment center in Tanzania. GHI is recruiting one intern to support study activities in Summer 2017. Intern activities may include assisting with patient enrollment, data management and cleaning, and preliminary data analysis. This opportunity is open to undergraduate or medical students with an interest in infectious disease, clinical research, and prior research experience.
Students interested in undertaking an internship must submit a Global Health Internship Application. Candidates may preference up to three internship sites during a single application cycle and are required to answer a short supplemental question for each site. Candidates are required to submit transcripts, a writing excerpt, and one to two letters recommendation at the time of application. All applications are due on February 17, 2015 at 11:59pm.
Please direct questions about the program to Anne Sosin, Global Health Initiative Program Manager.
Wednesday, February 17, 2016 - 5:00pm